About CellVax Therapeutics
CellVax Therapeutics is a private company based in Miami, Florida, incorporated in 2020 in Delaware. It has reported $2,084,999 raised in one offering on Form D since October 2024. Its chief executive is Fernando Kreutz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 19, 2024 | Oct 4, 2024 | $2,084,999of $4.9M target | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CellVax Therapeutics's Form D filed Oct 4, 2024.
FK
Fernando Kreutz
Chief Executive Officer and director
AS
Alberto da Costa Stein
Director